re: AUPH - Aurinia Pharmaceuticals

This one is such a huge portion of portfolio that MAN it sucks on days like this

If I didn't own any of it at all, I'd be thinking very hard about scaling in starting here...

Thinking seriously about buying another 400 shares. Someone talk me out of it.

"Feb 25th - Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team

Max Colao brings nearly 30 years of world-class commercial operations experience to his role at Aurinia. Prior to leading U.S. commercial operations at Alexion and launching multiple rare disease therapies, Mr. Colao spent nearly 20 years at Amgen, holding roles of increasing responsibility on various marketing and sales teams, most notably leading U.S. launches, commercialization, and pricing strategy in the areas of rheumatology, dermatology, and autoimmune disorders for Enbrel®, Prolia®, and Nplate®. Most recently, he was Chief Commercial Officer and Head of Business Development at Abeona, where he led the company’s commercialization and business development efforts of autologous cell therapy and AAV9-based gene therapy for rare diseases. Mr. Colao received his B.S. in applied mathematics and economics from the University of California, Los Angeles and his MBA from the University of Southern California."

Taking a pretty good hit today.

quote:

---

So, do you suppose this is more support for the go it alone projection?

---

I think yes. They must be fully prepared to go it alone.

And if they do you’ll see $80-100 per share in three years. It’s a win/win for those who have patience.

11% punch in the giblets today.

I’m in it for the long haul.

quote:

---

I’m in it till it hits $40

---

Likely two trial updates and FDA approval before July

It was my fault. I bought a day before the earnings announcement. Great report, yet the stock tanked.